Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension

This publication has 26 references indexed in Scilit:

• Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension
  JAMA Cardiology, 2023
• Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
  The Lancet, 2021
• Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension
  JAMA Cardiology, 2020
• Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka
  JAMA, 2018
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
  JACC, 2018
• Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality
  JAMA Cardiology, 2017
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
  The Lancet, 2015
• Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
  The Lancet, 2014
• Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models
  Pharmaceutical Statistics, 2013
• Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
  The American Journal of Medicine, 2009